by John-Michael Dumais, Childrens Health Defense:
Hebrew University scholar Josh Guetzkow, Ph.D., told John Campbell, Ph.D., the Pfizer-BioNTech vaccine rolled out to the public has bacterial contaminants and lower mRNA integrity compared to the version Pfizer used in its clinical trials.
The COVID-19 vaccine Pfizer-BioNTech rolled out to the world was not the same version that the vaccine maker used for its clinical trials, but an inferior formulation with significant impurities, according to Josh Guetzkow, Ph.D., assistant professor at the Hebrew University of Jerusalem.
TRUTH LIVES on at https://sgtreport.tv/
These impurities stem from a different manufacturing process and may be responsible for many of the injuries and deaths reported after the administration of the COVID-19 vaccine.
Guetzkow discussed these claims in a video podcast last week hosted by John Campbell, Ph.D., a prominent internet lecturer, retired emergency room nurse, teacher and author of two nursing textbooks.
Guetzkow, who admitted to not being an expert on “all of the biology and the manufacturing methods,” identified the two methods Pfizer-BioNTech used: Process 1 and Process 2.
Process 1 — used to manufacture the vaccine for clinical trials — was made by using a PCR (polymerase chain reaction) process to duplicate DNA. The DNA was then used to generate the mRNA strands via in vitro transcription.
“It’s relatively clean to do it that way and they were also using a very, very high-quality system [of] magnetic beads to take out any impurities,” Guetzkow said.
Campbell reminded viewers the PCR test was used during the pandemic to sample RNA from the nose and duplicate it — first turning into DNA via reverse transcriptase — in order to determine the presence of SARS-CoV-2.
“Of course, there’s a debate about that and how much it should be duplicated and whether that can give rise to false positive results,” he added.
In Process 2, Guetzkow said, a DNA template is inserted into a plasmid inside E. coli bacteria cells. The bacteria multiply, replicating the plasmids, which in turn multiply their DNA payload. The DNA is then extracted, linearized (chemically snipped from its circular form) and used to synthesize the mRNA strands for the vaccines.
Guetzkow said Process 2 is a more cost-effective, scalable way to make RNA. “Instead of having to put it in a PCR machine, you just have these big vats,” he said.
The problem with this method, according to Guetzkow, is that because the plasmid DNA and the bacteria are still mixed after replication, they need to be cleaned and purified.
“And that’s where they seem to have done a terrible job,” he said.
Guetzkow told Campbell he pieced together his findings from documents submitted by Pfizer to regulators like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and from clinical trial data released by the FDA, Freedom of Information Act requests to regulators like the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA), and from leaked and hacked EMA data and published studies.
Read More @ ChildrensHealthDefense.org
